Technology

BiondVax Pharmaceuticals

$3.66
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.15 (+4.17%) Today
-$0.09 (-2.40%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell BVXV and other stocks, options, and ETFs commission-free!

About BVXV

BiondVax Pharmaceuticals Ltd. American Depositary Shares, also called BiondVax Pharmaceuticals, is a clinical stage biopharmaceutical company focused on developing and commercializing immunomodulation therapies for infectious diseases. It works on M-001, a synthetic peptide-based protein targeting both seasonal and pandemic strains of the influenza virus. The company was founded by Ron Babecoff and Rami Epstein on July 22, 2003 and is headquartered in Jerusalem, Israel. The listed name for BVXV is BiondVax Pharmaceuticals Ltd. American Depositary Shares.

CEO
Ronald Babecoff
Employees
25
Headquarters
Jerusalem, Jerusalem
Founded
2003
Market Cap
42.24M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
682.70K
High Today
$3.76
Low Today
$3.42
Open Price
$3.55
Volume
341.34K
52 Week High
$62.00
52 Week Low
$2.35

Collections

BVXV Earnings

-$0.05
-$0.03
-$0.02
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
—

You May Also Like

AAOI
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure